ArticleBMC medicine2026
Scoping review on the prioritisation of high-consequence infectious pathogens for research preparedness and response to health emergencies.
Article in BMC medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundFunding for health research is intrinsically limited; therefore, priority-setting is necessary to optimise investments. Prioritisation is particularly important for epidemic and pandemic pathogens, as preparedness needs for hypothetical threats can be difficult to assess, and response during outbreaks requires accelerated decision-making. Exercises which prioritise epidemic and pandemic pathogens have been published; however, to our knowledge, there has been no systematic analysis of how, why and by whom these exercises are conducted. Guidelines and good practices for prioritisation exist, but whether these are followed for pathogen prioritisation and the consequences on the quality and impact of results has not yet been analysed.
methodsWe undertook a scoping review to investigate processes and methods of analysis reported across pathogen priority-setting exercises. We ran a grey literature search on Overton and Google to identify relevant resources published since 2018. The resources were screened by independent reviewers and extracted data were analysed using descriptive statistics and narrative synthesis.
resultsThe identified pathogen prioritisation exercises varied in geographical scope and included exercises focusing on specific threats such as antimicrobial resistance, as well as all-hazard prioritisation activities. We identified differences in the types of participants involved and their roles in priority-setting processes. While a diversity of processes and methods of analysis exist, there were common practices and steps, notably identifying candidate priority pathogens and developing assessment criteria, and then scoring the former against the latter to reach a final priority list. There were commonalities in the criteria themes used to score pathogens, such as severity of disease, transmissibility, prevalence, impact and mitigation measures. Rabies and influenza A were the two most reported priority list pathogens. Our ability to synthesise a meaningful ordered priority list across publications was limited by discrepancies in taxonomy and scope.
conclusionsThis study provides the first examination of priority setting exercises identifying high-consequence infectious pathogens. The review reveals important elements of commonality and variability between priority-setting exercises, highlighting areas for improvement to increase the comparability and quality of future efforts and their implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.